Today Genesis Healthcare (NYSE:GEN) Has Been Upgraded by Stifel Nicolaus to a “Buy”

Genesis Healthcare (NYSE:GEN) Stock Upgrade

In analysts note released on Wednesday morning, research analysts at the Stifel Nicolaus equities division increased shares of Genesis Healthcare (NYSE:GEN) to a respectable “Buy” rating. They now have a target price per share set at $2.5000 on GEN equating to 57.23 % more upside.

Genesis Healthcare, Inc. (NYSE:GEN) Ratings Coverage

Among 2 analysts covering Genesis Healthcare (NYSE:GEN), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Genesis Healthcare has $2.5 highest and $1.75 lowest target. $2.13’s average target is 33.96% above currents $1.59 stock price. Genesis Healthcare had 2 analyst reports since October 16, 2018 according to SRatingsIntel. The rating was upgraded by Stifel Nicolaus to “Buy” on Thursday, November 29.

The stock increased 5.30% or $0.08 during the last trading session, reaching $1.59. About 306,325 shares traded or 11.82% up from the average. Genesis Healthcare, Inc. (NYSE:GEN) has risen 28.97% since December 2, 2017 and is uptrending. It has outperformed by 13.35% the S&P500.

Genesis HealthCare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company has market cap of $257.07 million. The firm operates through three divisions: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It currently has negative earnings. It also provides a range of rehabilitation therapy services, including speech pathology, physical therapy, occupational therapy, and respiratory therapy.

More notable recent Genesis Healthcare, Inc. (NYSE:GEN) news were published by: Globenewswire.com which released: “Genesis HealthCare Reports Solid Third Quarter 2018 Results – GlobeNewswire” on November 07, 2018, also Seekingalpha.com with their article: “Healthcare and Services tops midday movers – Seeking Alpha” published on November 29, 2018, Seekingalpha.com published: “NAR: TSMC close to IBM chip order – Seeking Alpha” on November 19, 2018. More interesting news about Genesis Healthcare, Inc. (NYSE:GEN) were released by: Gurufocus.com and their article: “Sprint Takes Manhattan for Fastest Download Speeds and Data Reliability – GuruFocus.com” published on November 29, 2018 as well as Seekingalpha.com‘s news article titled: “Genesis Healthcare, Inc. (GEN) CEO George Hager on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: November 08, 2018.

Genesis Healthcare, Inc. (NYSE:GEN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.